DALLAS – Kendall Law Group, led by former federal judge Joe Kendall, is investigating Dionex Corp. (NASDAQ: DNEX) for shareholders in connection with the proposed acquisition by Thermo Fisher Scientific. The national securities firm’s investigation seeks to determine whether Dionex and its Board breached their fiduciary duties by entering into the agreement without properly shopping […]
Dionex Corporation (NasdaqGS: DNEX) shareholder litigation in connection with alleged unfair takeover offer On December 13, 2010, Dionex Corporation (“Dionex” or the “Company”) announced that it has agreed to sell the Company to Thermo Fisher Scientific (“Thermo Fisher”) (NYSE: TMO). Under the terms of the transaction, Thermo Fisher will acquire all of the outstanding shares […]
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/dnex) is investigating potential claims against the board of directors of Dionex Corporation (“Dionex” or the “Company”) (NASDAQ: DNEX) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s efforts to sell Dionex to Thermo Fisher Scientific in a transaction valued at approximately $2.1 billion. Our […]
NEW YORK – Bernstein Liebhard LLP is investigating whether the Board of Directors of Dionex Corporation (“Dionex” or the “Company”) (NASDAQ:DNEX) breached its fiduciary duty to its shareholders in agreeing to sell Dionex to Thermo Fisher Scientific Inc. Under the terms of the agreement, Dionex shareholders will receive $118.50 in cash for each share they […]
DALLAS – Goldfarb Branham LLP is investigating whether certain officers and directors of Dionex, Inc. (NASDAQ: DNEX) breached duties to shareholders by entering into a transaction to sell the company for $118.50 per share. Concerned stockholders are welcome to contact securities lawyer Hamilton Lindley at 877-583-2855 or hlindley@goldfarbbranham.com about their rights and remedies. Our proposed […]
HOLLISTON, Mass. -Harvard Bioscience, Inc. (“Harvard Bioscience,” or the “Company”) (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors […]
Three key patents for semiconductor-based nucleotide detection awarded in United States, China and Europe London, United Kingdom, DNA Electronics Ltd, a fabless provider of semiconductor solutions for real-time DNA and RNA detection, announced today the company has been awarded three key patents for semiconductor-based nucleotide detection. These latest patent allowances in the United States, China […]
Oxford Instruments-TDI, a world leader in the development of Hydride Vapour Phase Epitaxy (HVPE) processes and techniques for the production of novel compound semiconductors such as GaN, AlN, AlGaN, InN, InGaN, has just entered into a licensing agreement with The Fox Group. This agreement is for the acquisition of certain intellectual property, allowing Oxford Instruments-TDI […]
Broad Patent Covers the Revolutionary Sequence Design Technology Embedded in DNA2.0’s Free Gene Design Application Menlo Park, CA – BIOTECHNICA (https://www.biotechnica.de/), Hannover: DNA2.0 (https://www.dna20.com), the leading gene synthesis and protein engineering company, today announced that it has attained a patent through the U.S. Patent and Trade Office for the dynamic drag-and-drop- sequence functionality to create […]
BUDAPEST, HUNGARY, PRINCETON, NJ and LONDON – ThalesNano today reported that the US Patent and Trademark Office (USPTO) has granted a patent for its industry leading H-Cube®, including several aspects of its proprietary underlying technology. The H-Cube® is a revolutionary flow hydrogenation system developed for use by the pharmaceutical, fine chemical, petrochemical, biotechnology and related […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
